Skip to main content
. 2021 Jun 28;48(8):4139–4147. doi: 10.1002/mp.14993

Table III.

Plan parameter comparisons for AUTO RB and REF plans.

REF AUTO RB AUTO RB ‐ REF
Mean (min, max) Mean (min, max)
Δ
(min, max) P
PTV
D98\%
34.7 (29.3, 36.8) 35.1 (33.2, 36.3) 0.4 (−1.1, 3.8) 0.02
D0.03cc
60.2 (56.0, 61.8) 59.1 (54.7, 61.8) −1.1 (−3.4, 1.9) <0.001
Urethra
D5\%
40.5 (38.8, 41.5) 40.3 (38.1, 42.0) −0.2 (−1.5, 1.3) 0.1
D10\%
40.0 (38.4, 41.1) 39.8 (37.8, 41.5) −0.2 (−1.2, 1.0) 0.03
D50\%
38.6 (35.1, 39.9) 38.1 (35.1, 40.0) −0.6 (−1.4, 0.6) <0.001
Rectum
V32.3Gy
0.5 (0.0, 1.0) 0.4 (0.0, 1.1) −0.0 (−0.5, 0.7) 0.3
D0.03cc
35.5 (32.8, 37.0) 36.4 (28.8, 38.0) 0.8 (−6.3, 4.9) 0.004
Dmean
7.2 (4.7, 9.5) 6.8 (4.4, 10.0) −0.4 (−3.3, 2.5) 0.03
Mucosa
D0.03cc
24.8 (20.7, 27.2) 24.0 (12.8, 28.5) −0.8 (−11.2, 7.8) 0.3
Bladder
V38Gy
0.3 (0.0, 0.9) 0.4 (0.1, 0.9) 0.1 (−0.2, 0.3) <0.001
D0.03cc
39.4 (37.8, 40.6) 40.1 (38.5, 41.4) 0.7 (−1.6, 2.2) <0.001
Dmean
9.1 (6.8, 12.9) 8.2 (5.0, 12.1) −0.9 (−2.7, 2.8) <0.001
Entrance
D1cc
17.3 (14.2, 19.9) 17.2 (12.9, 21.4) −0.0 (−4.4, 3.4) 0.9
Left FH
D0.03cc
13.2 (7.4, 17.6) 15.4 (11.3, 19.4) 2.2 (−1.7, 5.7) <0.001
Right FH
D0.03cc
15.1 (9.7, 18.6) 15.6 (11.5, 19.9) 0.5 (−3.3, 4.2) 0.2
Conformality 0.82 (0.75, 0.88) 0.78 (0.72, 0.84) −0.04 (−0.07, −0.01) <0.001
Beams 48.3 (37.0, 59.0) 38.0 (29.0, 49.0) −10.4 (−23.0, −2.0) <0.001
Segments 98.9 (54.0, 167.0) 61.5 (40.0, 105.0) −37.5 (−118.0, 37.0) <0.001
MU/fx [×1000] 6.1 (4.9, 8.9) 6.2 (4.7, 7.4) 0.1 (−2.5, 1.8) 0.2
ETT [min] 22.3 (17.0, 32.0) 18.6 (15.0, 24.3) −3.7 (−11.7, 4.0) <0.001

Doses (Dxx) presented in Gy and volumes (Vxx) in cc. Entrance dose was evaluated using D1cc of a ring structure of 3 cm thickness inside the patient's external contour. FH: Femoral head, MU/fx: Monitor Units per fraction, ETT: Estimated treatment time.

Bold indicates statistically significant P‐value